Amyloid precursor protein 770 is specifically expressed and released from platelets-Reference-Cited by-同舟云学术

Amyloid precursor protein 770 is specifically expressed and released from platelets

Published:2020-09 Issue:38 Volume:295 Page:13194-13201
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Miura Saori,Yoshihisa Akiomi,Misaka Tomofumi,Yamaki Takayoshi,Kojima Takao,Toyokawa Masahiro,Ogawa Kazuei,Shimura Hiroki,Yamamoto Naomasa,Kasahara Kohji,Takeishi Yasuchika,Kitazume Shinobu

Funder

Japan Agency for Medical Research and Development

MEXT | Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference39 articles.

1. Platelet activation and atherothrombosis;Davì;N. Engl. J. Med.,2007

2. Platelets in atherothrombosis;Ruggeri;Nat. Med.,2002

3. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Patrono;Chest,2004

4. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting;Leon;N. Engl. J. Med.,1998

5. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes;Larsen;Cell,1989

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The reciprocal relationship between amyloid precursor protein and mitochondrial function;Journal of Neurochemistry;2024-07-18

2. Cerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers;TrAC Trends in Analytical Chemistry;2023-09

3. Nanotherapeutic approaches for managing phospholipase-mediated neurodegenerative and metabolic diseases;Phospholipases in Physiology and Pathology;2023

4. Extracellular vesicles: A new paradigm in understanding, diagnosing and treating neurodegenerative disease;Frontiers in Aging Neuroscience;2022-11-03

5. Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease;Frontiers in Aging Neuroscience;2022-09-07